Which Preoperative Chemotherapy Regimen in Gastric Cancer Is Least Preferred?

Article

Do you know how many men and women are estimated to be diagnosed with gastric cancer this year? How about some of the known risk factors for this disease? Test your knowledge in our latest quiz.

Do you know how many men and women are estimated to be diagnosed with gastric cancer this year? How about some of the known risk factors for this disease? Test your knowledge in our latest quiz.

Question 1

Answer

C.Paclitaxel/fluorouracil

Question 2

Answer

C. 28,000

According to estimates from the American Cancer Society, 17,750 men and 10,250 women will be diagnosed with gastric cancer this year.

Question 3

Answer

D.Absence of known risk factors (H. pylori infection, smoking, high salt intake)

Question 4

Answer

B. 10,960

According to estimates from the American Cancer Society, 6,720 men and 4,240 women will die from gastric cancer this year.

Question 5

Answer

E.All of the above

Other risk factors include smoking, H. pylori or Epstein–Barr infections, smoking, and BRCA1/2 mutations.

Recent Videos
Additional genetic testing measures and targeted therapies may improve outcomes for patients with diverse molecular subgroups of gastric cancers.
Data from the SPOTLIGHT and GLOW trials reveal that zolbetuximab increased survival in patients with CLDN18.2-positive gastric or GEJ adenocarcinoma.
The incorporation of zolbetuximab in addition to chemotherapy has shown benefit in patients with Claudin 18.2–positive gastric cancers in clinical trials.
Related Content